» Articles » PMID: 9514856

Enhanced and Specific Gene Expression Via Tissue-specific Production of Cre Recombinase Using Adenovirus Vector

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1998 Mar 26
PMID 9514856
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

A tissue-specific promoter is potentially valuable for the study of specific gene function and for gene therapy, as it permits a linked cytotoxic or any other gene to be expressed specifically in target cells. The expression levels of such promoters are generally low, and we have therefore developed a novel and general method to enhance the expression level of a tissue-specific promoter while maintaining specificity. We constructed a "regulator" recombinant adenovirus (rAd) producing the site-specific recombinase Cre under the control of the hepatocarcinoma-specific alpha-fetoprotein (AFP) promoter. The rAd was infected to AFP-producing cells together with a "target" rAd containing a Cre-activating potent expression unit. In in vitro experiments, the double infection method gave about 50-fold higher expression than the single rAd infection directly driven by the AFP promoter, while maintaining strict specificity to AFP-producing cells. The enhanced and specific expression was also observed in in vivo tumor models. This method may contribute not only to the establishment of specific gene therapies but also to basic study for elucidating cell-type specific gene functions.

Citing Articles

Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma.

Singh V, Pathak S, Kumar N, Jayandharan G ACS Omega. 2024; 9(28):30945-30953.

PMID: 39035883 PMC: 11256310. DOI: 10.1021/acsomega.4c03949.


Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters.

Montano-Samaniego M, Bravo-Estupinan D, Mendez-Guerrero O, Alarcon-Hernandez E, Ibanez-Hernandez M Front Oncol. 2020; 10:605380.

PMID: 33381459 PMC: 7768042. DOI: 10.3389/fonc.2020.605380.


miRNA122a regulation of gene therapy vectors targeting hepatocellular cancer stem cells.

Dhungel B, Ramlogan-Steel C, Layton C, Steel J Oncotarget. 2018; 9(34):23577-23588.

PMID: 29805757 PMC: 5955118. DOI: 10.18632/oncotarget.25280.


Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions.

Yoon A, Hong J, Kim M, Yun C Sci Rep. 2018; 8(1):2233.

PMID: 29396500 PMC: 5797125. DOI: 10.1038/s41598-018-20268-6.


Preferable sites and orientations of transgene inserted in the adenovirus vector genome: The E3 site may be unfavorable for transgene position.

Suzuki M, Kondo S, Pei Z, Maekawa A, Saito I, Kanegae Y Gene Ther. 2015; 22(5):421-9.

PMID: 25588742 PMC: 4424821. DOI: 10.1038/gt.2014.124.